BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 5605712)

  • 41. Effect of propranolol (inderal) on exercise tolerance in angina pectoris.
    Hamer J; Grandjean T; Melendez L; Sowton GE
    Br Heart J; 1966 May; 28(3):414-8. PubMed ID: 5327848
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of anaprilin on hemodynamics and cardiac rhythm].
    Zharko KP
    Vrach Delo; 1971 Jul; 7():33-6. PubMed ID: 4399348
    [No Abstract]   [Full Text] [Related]  

  • 43. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapy with beta-blocking agents in cardiology].
    Dal Palù C
    Minerva Med; 1970 Nov; 61(95):5450-8. PubMed ID: 4395227
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapy of coronary insufficiency with beta-adrenergic blocking agents].
    De Maestri C; Rinaldi AR
    Boll Soc Med Chir Cremona; 1967; 21(3):125-32. PubMed ID: 5597563
    [No Abstract]   [Full Text] [Related]  

  • 46. The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
    Piatak OA; Yanovskii GV; Lizogub VG
    Cor Vasa; 1991; 33(1):19-25. PubMed ID: 1655353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of vitamin B 15 on myocardial contractility and cardiotonic effect of strophanthin in ischaemic heart disease.
    Apanasenko AA
    Cor Vasa; 1973; 15(1):20-8. PubMed ID: 4703670
    [No Abstract]   [Full Text] [Related]  

  • 48. [On strophanthin therapy. Advantages and disadvantages].
    Effert S; Meyer J
    Dtsch Med Wochenschr; 1967 Sep; 92(36):1637-9. PubMed ID: 6051288
    [No Abstract]   [Full Text] [Related]  

  • 49. [Remote results of treatment of angina pectoris with various types of drugs blocking beta adrenergic receptors].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1972 May; 27(20):752-4. PubMed ID: 4402234
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chronic administration of beta blocking agents: left ventricular hemodynamics in myocardial infarctions during exercise (author's transl)].
    Blümchen G; Esche HH
    Z Kardiol; 1981 Sep; 70(9):678-86. PubMed ID: 7303806
    [No Abstract]   [Full Text] [Related]  

  • 51. [Beta adrenergic receptor blocking agents in the treatment of arrhythmia and angina pectoris].
    Fülöp T; Szodoray P
    Orv Hetil; 1969 Oct; 110(41):2387-94. PubMed ID: 5358359
    [No Abstract]   [Full Text] [Related]  

  • 52. [The use of an adrenergic beta-receptor blocking agent in coronary insufficiency and heart rhythm disorders].
    Doshchitsyn VL
    Kardiologiia; 1966; 6(5):65-9. PubMed ID: 6000275
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 54. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol].
    Liljedal J
    Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of Molsidomin on the hemodynamics and working tolerance of patients with angina pectoris].
    Slany J; Mösslacher H; Schmoliner R; Krinik G
    Med Welt; 1976 Dec; 27(49):2396-2400. PubMed ID: 796622
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical and hemodynamic appraisal of beta adrenergic blocking drugs.
    Epstein SE; Braunwald E
    Ann N Y Acad Sci; 1967 Feb; 139(3):952-67. PubMed ID: 5342364
    [No Abstract]   [Full Text] [Related]  

  • 57. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical impressions of a new beta-adrenergic blocking drug, 39,089-Ba.
    Wilson DF; Turner AS
    N Z Med J; 1967 Oct; 66(422):682-3. PubMed ID: 4864443
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antianginal and hemodynamic effect of propranolol and atenolol in patients with exertion angina].
    Desiatnichenko VM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):71-5. PubMed ID: 6508931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacodynamic comparison of propranolol and verapamil in exertion stenocardia].
    Sumarokov AB; Romakov AIu; Sagirov AM; Iurkova VB; Mazur NA
    Klin Med (Mosk); 1984 Mar; 62(3):42-6. PubMed ID: 6716929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.